Guided Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2015 | — | — | $8.0K | $1.0M |
| FY2016 | $-1.8M | $-1.8M | $0 | $95.0K |
| FY2017 | $-1.1M | $-1.1M | — | $59.0K |
| FY2018 | $-1.4M | $-1.4M | — | $44.0K |
| FY2019 | $-806.0K | $-806.0K | $0 | $8.0K |
| FY2020 | $-1.9M | $-1.9M | $1.0K | $309.9K |
| FY2021 | $-1.6M | $-1.6M | $14.0K | $228.0K |
| FY2022 | $-1.5M | $-1.5M | $31.0K | $1.4M |
| FY2023 | $-1.7M | $-1.7M | $0 | $1.8M |
| FY2024 | $-1.1M | $-1.1M | $0 | $120.0K |
| FY2025 | $-1.1M | $-1.1M | $2.0K | $377.0K |